AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2021
May 19, 2021
33298_dirs_2021-05-19_68b0fbe0-03c1-4803-b40c-e33820ca5d1e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2021-05-19
Reporting Person: Yecies Eric Harold (CCO and General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-19 | Common Stock | P | 11100 | $9.24 | Acquired | 16100 | Direct |
Footnotes
F1: The price reported represents the weighted average price of shares purchased. The shares were purchased at varying prices in the range of $9.18 - $9.30. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each price.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17